卵巢癌患者血清CA125、TGF-β_1和HE4联检的临床意义
摘要
本文对卵巢癌患者进行了血清CA125、TGF—β1和HE4测定，并就临床价值作初步探讨，现将结果报告如下。
出处
《放射免疫学杂志》
CAS
2013年第3期382-383,共2页
Journal of Radioimmanology
参考文献6
-
1Moore RG,Memeekin DS,Browm AK,et al. A novel multi -pie mark- er bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass[ J]. Gynecol Oncol,2009,112:40-46.
-
2王锋,廖予妹,王武亮,黄冬梅.卵巢癌患者血清人附睾分泌蛋白4和CA125的检测及其诊断意义[J].中国综合临床,2010,26(1):92-94. 被引量：13
-
3Shummer M, Ng WV, Bumgamer RE, et al. Comparative hybridiza- tion of an array of 21,500 ovarian cDNA for the discovery of genes overex- pressed in ovarian carcinomas[ J]. Gene, 1999,238:375-385.
-
4陈晓超.卵巢癌患者血清Hcy、HE4和SA联检的临床意义[J].放射免疫学杂志,2012,25(2):187-188. 被引量：3
-
5刘娟,生秀杰.TGF-β1在卵巢上皮性癌的表达水平及意义[J].现代肿瘤医学,2010,18(1):131-132. 被引量：10
-
6黄梅.卵巢癌患者手术治疗前后血清NO、NOS、TGF-β_1和TSGF检测的临床意义[J].放射免疫学杂志,2012,25(2):189-190. 被引量：2
二级参考文献37
-
1孔丽,胡云龙,赵三江,刘金星.原发性肝癌患者血清TGFβ1和IL-8水平与预后的关系[J].天津医药,2005,33(12):754-755. 被引量：22
-
2王官将,陈克明,姜关祥,杨林,伍军,傅鹏.快速测定血清唾液酸的新方法[J].第二军医大学学报,1990,11(4):361-363. 被引量：56
-
3Lesley D, Elizabeth J, Mark W. TGFβ - induced smad signaling remain intact in primary human ovarian cancer cells[ J]. Endocrinol- ogy,2002,143(4) : 1174 - 1181.
-
4Narai S, Watanabe M, Hasegawa H, et al. Significance of transforming growth factor betal as a new tumor marker for colorectal cancer[J]. Int J Cancer,2002,97(4) : 508 -511.
-
5Shariat SF, Kim JH, Andrews B, et al. Preoperative plasma levels of transforming growth factor beta (1) strongly predict clinical outcome in patients with bladder carcinoma [ J]. Cancer, 2001,92 (12) :2985 -2992.
-
6Niki M, Okajima K, Isozaki H, et al. Measurement of the plasma transforming growth factor - beta 1 ( TGF - beta 1 ) level in patients of gastric carcinoma - compared with the serum IAP level and the lymphocyte subsets ( CD3, CD4, CD8 ) [ J ]. Nippon Shokakibyo Gakkai Zasshi,1996,93(5) : 303 -311.
-
7Zhou Q,Dong Wang L,Du F,et al. Changes of TGFbetal and TG- FbetaRⅡ expression in esophageal precancerous and cancerous lesions : a study of a high - risk population in Henan, northern China [J]. Dis Esophagus,2002,15(1) : 74-79.
-
8Maehara Y, Kakeji Y, Kabashima A, et al. Role of transforming growth factor - β1 in invasion and metastasis in gastric cancer[J]. J Clin Oncol,1999,17:607 -614.
-
9Sheen - Chen SM, Chen HS, Sheen CW, et al. Serum levels of transforming growth factor betal in patients with breast cancer[ J]. Arch Surg,2001,136(8) : 937 -940.
-
10Ivanovic V, Todorovic - Rakovic N, Demajo M, et al. Elevated plasma levels of transforming growth factor - beta 1 ( TGF - beta 1 ) in patients with advanced breast cancer: association with disease progression[ J]. Eur J Cancer,2003,39(4) : 454 -461.
共引文献24
-
1梁宏峰,张浩,马秀岩.溶血磷脂酸及CA125在卵巢癌诊断中的价值对比分析[J].中国综合临床,2011,27(4):348-350. 被引量：6
-
2杨春玲,夏薇,张桂杰,周杰.血清CA125、CA72-4与人附睾分泌蛋白4检测在卵巢癌早期诊断中的临床价值[J].中国综合临床,2011,27(4):358-360. 被引量：11
-
3蔡冬梅,刘蓉.转化生长因子-β1在上皮性卵巢癌中的表达及意义[J].交通医学,2011,25(3):244-247. 被引量：3
-
4朱亚飞,高国兰,黄清水,唐俊.血清人附睾分泌蛋白4(HE4)对人卵巢癌诊断价值的Meta分析[J].中国肿瘤临床,2011,38(24):1559-1564. 被引量：9
-
5杨曙,王希成,莫凯岚,彭苗,丁颖.卵巢癌中转化生长因子β及其受体表达与病理特征的关系[J].临床医学工程,2012,19(9):1467-1469. 被引量：1
-
6吕煊.检测液基细胞学的腹水CA125对卵巢癌的诊断价值[J].中外医学研究,2012,10(24):41-42. 被引量：2
-
7屈娜,郭科军.卵巢癌血清人附睾分泌蛋白4表达水平的Meta分析[J].中华肿瘤防治杂志,2012,19(16):1258-1262. 被引量：6
-
8张莹,姜付显.卵巢上皮性癌血清肿瘤标志物的研究进展[J].现代药物与临床,2012,27(5):507-511. 被引量：4
-
9刘青,董佳,林一,王厚照.血清中人附睾分泌蛋白4和CA125联合检测在卵巢癌发病风险预测中的价值[J].职业与健康,2012,28(19):2364-2365. 被引量：1
-
10彭晔,张旭刚,王艳玲,杨秀芳,周立强,胡洁.转化生长因子-β1与恶性肿瘤关系的临床研究进展[J].中国全科医学,2013,16(2):232-234. 被引量：6
